Introduction: Calcium flux is the master second messenger that influences the proliferation-apoptosis balance. The ability of calcium flux alterations to reduce cell growth makes ion channels interesting targets for therapy. Among all, we focused on transient receptor potential vanilloid 1, a ligand-gated cation channel with selectivity for calcium. Its involvement in hematological malignancies is poorly investigated, especially in the field of chronic myeloid leukemia, a malignancy characterized by the accumulation of immature cells.Methods: FACS analysis, Western blot analysis, gene silencing, and cell viability assay were performed to investigate the activation of transient receptor potential vanilloid 1, by N-oleoyl-dopamine, in chronic...
Patients treated during leukemia face the risk of complications including pulmonary dysfunction that...
Esophageal squamous cell carcinoma (ESCC) is the sixth leading cause of death due to cancer, indicat...
Imatinib induces a complete cytogenetic regression in a large percentage of patients affected by chr...
International audienceBackground: Chronic myeloid leukemia (CML) results from hematopoietic stem cel...
To overcome the drug resistance phenomenon induced by Imatibib (IM), in clinical practice, are often...
Chronic myeloid leukemia (CML) is a hematopoietic stem cell disorder caused by the oncogenic activit...
International audienceAcute myeloid leukemia (AML) is a clonal disorder characterized by genetic abe...
Abstract Chronic myeloid leukemia (CML) is a hematopoietic stem cell disorder caused by the oncogen...
Multiple myeloma (MM) is a hematological malignancy characterized by the neoplastic proliferation of...
Multiple myeloma (MM) is a currently incurable hematologic cancer. Patients that initially respond t...
Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by accumulation of imm...
Cancer cells acquire the ability to modify the calcium signaling network by altering the expression ...
Patients treated during leukemia face the risk of complications including pulmonary dysfunction that...
Esophageal squamous cell carcinoma (ESCC) is the sixth leading cause of death due to cancer, indicat...
Imatinib induces a complete cytogenetic regression in a large percentage of patients affected by chr...
International audienceBackground: Chronic myeloid leukemia (CML) results from hematopoietic stem cel...
To overcome the drug resistance phenomenon induced by Imatibib (IM), in clinical practice, are often...
Chronic myeloid leukemia (CML) is a hematopoietic stem cell disorder caused by the oncogenic activit...
International audienceAcute myeloid leukemia (AML) is a clonal disorder characterized by genetic abe...
Abstract Chronic myeloid leukemia (CML) is a hematopoietic stem cell disorder caused by the oncogen...
Multiple myeloma (MM) is a hematological malignancy characterized by the neoplastic proliferation of...
Multiple myeloma (MM) is a currently incurable hematologic cancer. Patients that initially respond t...
Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by accumulation of imm...
Cancer cells acquire the ability to modify the calcium signaling network by altering the expression ...
Patients treated during leukemia face the risk of complications including pulmonary dysfunction that...
Esophageal squamous cell carcinoma (ESCC) is the sixth leading cause of death due to cancer, indicat...
Imatinib induces a complete cytogenetic regression in a large percentage of patients affected by chr...